Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 2
2011 2
2014 1
2015 2
2016 1
2018 2
2020 5
2021 3
2022 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial.
Andresen V, Gschossmann J, Layer P. Andresen V, et al. Lancet Gastroenterol Hepatol. 2020 Jul;5(7):658-666. doi: 10.1016/S2468-1253(20)30056-X. Epub 2020 Apr 8. Lancet Gastroenterol Hepatol. 2020. PMID: 32277872 Clinical Trial.
BACKGROUND: Bifidobacterium bifidum MIMBb75 is one of a few probiotic strains that have been shown to be effective in the treatment of irritable bowel syndrome (IBS) and its symptoms. ...No serious adverse events occurred in the B bifidum
BACKGROUND: Bifidobacterium bifidum MIMBb75 is one of a few probiotic strains that have been shown to be effective in the trea …
Antibiotics and Probiotics for Irritable Bowel Syndrome.
Goodoory VC, Ford AC. Goodoory VC, et al. Drugs. 2023 Jun;83(8):687-699. doi: 10.1007/s40265-023-01871-y. Epub 2023 May 15. Drugs. 2023. PMID: 37184752 Free article. Review.
Irritable bowel syndrome (IBS) is a disorder of a gut-brain interaction characterised by abdominal pain and a change in stool form or frequency. ...Current evidence also suggests that certain probiotics, including Lactobacillus plantarum DSM 9843 and Bifid
Irritable bowel syndrome (IBS) is a disorder of a gut-brain interaction characterised by abdominal pain and a change in
The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome-A Randomized Double-Blind, Placebo-Controlled Study.
Skrzydło-Radomańska B, Prozorow-Król B, Cichoż-Lach H, Majsiak E, Bierła JB, Kosikowski W, Szczerbiński M, Gantzel J, Cukrowska B. Skrzydło-Radomańska B, et al. Nutrients. 2020 Jul 5;12(7):1999. doi: 10.3390/nu12071999. Nutrients. 2020. PMID: 32635661 Free PMC article. Clinical Trial.
The purpose of the randomized double-blind placebo-controlled trial was to assess the effectiveness of synbiotic preparation containing probiotic Lactobacillus rhamnosus FloraActive 19070-2, Lactobacillus acidophilus DSMZ 32418, Bifidobacterium lactis DSMZ 32269, Bifido
The purpose of the randomized double-blind placebo-controlled trial was to assess the effectiveness of synbiotic preparation containing prob …
Bifidobacterium bifidum MIMBb75 in irritable bowel syndrome.
Quigley EM. Quigley EM. Aliment Pharmacol Ther. 2011 Jul;34(1):100-1; author reply 101. doi: 10.1111/j.1365-2036.2011.04671.x. Aliment Pharmacol Ther. 2011. PMID: 21631550 Free article. No abstract available.
Effect of Bifidobacterium bifidum G9-1 on the Intestinal Environment and Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)-like Symptoms in Patients with Quiescent Crohn's Disease: A Prospective Pilot Study.
Tomita T, Fukui H, Okugawa T, Nakanishi T, Mieno M, Nakai K, Eda H, Kitayama Y, Oshima T, Shinzaki S, Miwa H. Tomita T, et al. J Clin Med. 2023 May 9;12(10):3368. doi: 10.3390/jcm12103368. J Clin Med. 2023. PMID: 37240476 Free PMC article.
Diarrhea-predominant irritable bowel syndrome (IBS-D)-like symptoms are distressing for patients with quiescent Crohn's disease (qCD) and worsen their quality of life. In the present study, we assessed the effect of the probiotic Bifidobacterium bif
Diarrhea-predominant irritable bowel syndrome (IBS-D)-like symptoms are distressing for patients with quiescent Crohn's …
Evaluation of the efficacy of probiotics as treatment in irritable bowel syndrome.
Ruiz-Sánchez C, Escudero-López B, Fernández-Pachón MS. Ruiz-Sánchez C, et al. Endocrinol Diabetes Nutr (Engl Ed). 2024 Jan;71(1):19-30. doi: 10.1016/j.endien.2024.01.003. Epub 2024 Feb 7. Endocrinol Diabetes Nutr (Engl Ed). 2024. PMID: 38331656 Free article. Review.
Irritable bowel syndrome (IBS) is a gastrointestinal functional disorder mainly characterised by abdominal pain, bloating and altered bowel habits. ...Bifidobacterium bifidum reported the best results (1 10(9) CFU/day for 4 weeks). ...
Irritable bowel syndrome (IBS) is a gastrointestinal functional disorder mainly characterised by abdominal pain, bloati
Review on Bifidobacterium bifidum BGN4: Functionality and Nutraceutical Applications as a Probiotic Microorganism.
Ku S, Park MS, Ji GE, You HJ. Ku S, et al. Int J Mol Sci. 2016 Sep 14;17(9):1544. doi: 10.3390/ijms17091544. Int J Mol Sci. 2016. PMID: 27649150 Free PMC article. Review.
Bifidobacterium bifidum BGN4 is a probiotic strain that has been used as a major ingredient to produce nutraceutical products and as a dairy starter since 2000. The various bio-functional effects and potential for industrial application of B. bifidum BGN4 has
Bifidobacterium bifidum BGN4 is a probiotic strain that has been used as a major ingredient to produce nutraceutical products
Bacterial therapy for irritable bowel syndrome.
Talley NJ, Irani M, Keely S. Talley NJ, et al. Lancet Gastroenterol Hepatol. 2020 Jul;5(7):627-629. doi: 10.1016/S2468-1253(20)30079-0. Epub 2020 Apr 8. Lancet Gastroenterol Hepatol. 2020. PMID: 32277873 No abstract available.
Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
Guglielmetti S, Mora D, Gschwender M, Popp K. Guglielmetti S, et al. Aliment Pharmacol Ther. 2011 May;33(10):1123-32. doi: 10.1111/j.1365-2036.2011.04633.x. Epub 2011 Mar 21. Aliment Pharmacol Ther. 2011. PMID: 21418261 Free article. Clinical Trial.
BACKGROUND: Recent research suggests that an imbalance of the intestinal microbiota and a dysfunctional intestinal barrier might trigger irritable bowel syndrome (IBS). As probiotics have been reported to restore the intestinal microbiota and the gut barrier, …
BACKGROUND: Recent research suggests that an imbalance of the intestinal microbiota and a dysfunctional intestinal barrier might trigger …
The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia.
Marras L, Caputo M, Bisicchia S, Soato M, Bertolino G, Vaccaro S, Inturri R. Marras L, et al. Microorganisms. 2021 Apr 14;9(4):836. doi: 10.3390/microorganisms9040836. Microorganisms. 2021. PMID: 33919907 Free PMC article. Review.
The health benefits are strain specific and could be due to the produced polysaccharides. The consumption of probiotics may prevent obesity, irritable bowel syndrome, eczema or atopic dermatitis, and asthma. ...Bifidobacteria and lactobacilli may be used as p …
The health benefits are strain specific and could be due to the produced polysaccharides. The consumption of probiotics may prevent obesity, …
25 results